StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
GRI

GRI Bio, Inc.

GRI Nasdaq Pharmaceutical Preparations EDGAR ↗
$1.59
+0.15 +10.42%

Key statistics

from XBRL data in SEC filings
Market cap
$2.82M
Revenue (TTM)
$0.00
Net income (TTM)
-$10.9M
EPS (TTM)
$38.89
P/E ratio
0.0
Dividend yield
Free cash flow
-$10.2M
Cash
$11.0M
Total assets
$11.3M
Gross margin
52-week range
$1.36 – $80.36

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jun 18, 2026 8-K Results of operations (earnings release); Other events May 14, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) Feb 4, 2026 10-K Fiscal year ended 2025-12-31 Jan 30, 2026 8-K Entered a material agreement Jan 30, 2026 8-K Other events Jan 28, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Other events Jan 21, 2026 8-K Delisting notice or listing-rule failure Jan 16, 2026 8-K Shareholder vote results; Other events Jan 15, 2026 8-K Other events Jan 9, 2026 8-K Other events Jan 8, 2026 8-K Other events Dec 12, 2025 8-K Entered a material agreement Dec 12, 2025 8-K Other events Dec 10, 2025 8-K Other events Dec 8, 2025 8-K Delisting notice or listing-rule failure Dec 2, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Regulation FD disclosure Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Director or officer change; Shareholder vote results Aug 13, 2025 8-K Other events Jul 31, 2025 8-K Regulation FD disclosure Jun 26, 2025 8-K Other events May 23, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 8-K Other events May 5, 2025 8-K Changed accountants Apr 16, 2025 8-K Entered a material agreement; Other events Apr 2, 2025 8-K Results of operations (earnings release) Mar 17, 2025 10-K Fiscal year ended 2024-12-31 Mar 14, 2025 8-K Delisting notice or listing-rule failure; Other events Mar 11, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Feb 19, 2025 8-K Shareholder vote results Feb 11, 2025 8-K Other events Dec 20, 2024 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Other events Oct 24, 2024 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Other events Oct 22, 2024 8-K/A Delisting notice or listing-rule failure Sep 11, 2024